MP45-08 PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5I) USE AFTER RADICAL PROSTATECTOMY (RP) IS NOT ASSOCIATED WITH INCREASED RISK OF BIOCHEMICAL RECURRENCE RISK (BCR)

INTRODUCTION AND OBJECTIVE:The data on the association between PDE5i utilization and BCR after RP and PDE5i is mixed. We aimed to provide a better risk assessment based on exposure data.METHODS:Pat...